Who we are

Managed by Brandon Capital, Brandon BioCatalyst supports the development and commercialisation of early-stage biomedical discoveries originating from member research organisations, providing both capital and expertise to guide the successful development of new therapies.

Brandon BioCatalyst is a unique collaboration of investors, CSL, government and more than 50 leading medical research institutes and hospitals united by a single purpose: generating cutting edge, next generation medical therapies and technologies to improve health and save lives.

    Technologies, expertise

    50+ Medical research institutes and hospitals

    Operational support

    ACT Government
    NSW Government Health
    Government of South Australia
    Queensland Government
    Victorian Government
    Western Australian Government
    Ministry of Business, Innovation & Employment (MBIE) NZ

    Management

    Brandon Capital

    Independent Governance
    Investors

    Australian Government
    Australian Super
    Hesta
    Host Plus
    TelstraSuper
    CSL

Members

Institute
Robinson Research Institute

The Robinson Research Institute is a collective of internationally renowned researchers in human reproduction, pregnancy and child health at the University of Adelaide.

View
Institute
Australian Institute for Bioengineering and Nanotechnology

The University of Queensland's Australian Institute for Bioengineering and Nanotechnology (AIBN) is an integrated multi-disciplinary research institute bringing together the skills of world-class researchers in the areas of bioengineering and nanotechnology.

View
Institute
Hunter Medical Research Institute

The Hunter Medical Research Institute (HMRI) is NSW’s second largest medical research institute. Its pioneering partnership with the University of Newcastle and Hunter New England Local Health District delivers key translational research outcomes and technology closely aligned to community health needs. More than 1400 clinical and biomedical researchers and support staff are employed across seven HMRI Research Programs, striving to prevent, cure and treat a diverse range of serious illnesses.

View

Government Partners

Investors

Brandon BioCatalyst's investors are AustralianSuper, HESTA, HOSTPLUS, TelstraSuper, CSL and the Australian Government under its IIF and BTF programs.

Brandon Capital

Brandon Capital manages Brandon BioCatalyst, providing seed and venture capital investment to support the development and international growth of Australian and New Zealand life science companies.

Brandon Capital website